What Industries Benefit from Exposomics Analysis? How much does our environment influence our health—and what could that mean for precision medicine? Which industries can benefit from exposomics analysis? The answer extends beyond healthcare. In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explains how exposomics can provide valuable insights for drug development, precision […]
Is Exposomics the Missing Link in Precision Medicine? How much does our environment influence our health—and what could that mean for precision medicine? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explores how exposomics can help researchers understand the relationship between environmental chemical exposures and human health. From pollutants and pesticides to […]
How Are Environmental Chemicals Linked to Parkinson’s Disease? How are environmental chemical exposures linked to Parkinson’s disease, and what could these connections mean for drug development? In this episode of ChatGJP, Panome Bio CSO Gary J. Patti explores emerging research on environmental chemicals and their potential role in neurodegenerative disease. The conversation also dives into […]
Discovery Exposomics profiling of 30 serum samples identified 240 exposure chemicals, with 138 showing significant differences between Alzheimer’s disease and healthy control groups. The analysis revealed distinct exposure patterns and enrichment across chemical classes, highlighting differences in the broader chemical exposome associated with Alzheimer’s disease. Explore the enrichment profile below and discover the full findings […]
Targeted Exposomics profiling of 30 serum samples revealed distinct chemical exposure patterns associated with Alzheimer’s disease. Twenty-nine chemical exposures were detected, with several showing significant differences between Alzheimer’s disease and control groups. Explore the exposure profile below and discover the full findings in the data report. This data report has been redesigned for improved clarity. […]
Exposomics Reveals Differential Exposures And Chemical Subgroups ow can researchers identify which environmental chemicals differ between patient groups? How do they distinguish environmental exposures from naturally occurring metabolites? And how can machine learning uncover exposure patterns that researchers may not have anticipated? In this episode of ChatGJP, Ethan Stancliffe, Senior Director of R&D at Panome […]
Learn how untargeted metabolomics and lipidomics identify biomarkers that complement traditional methods for periodontitis diagnosis and oral health research.
Characterizing Chemical Exposures During Pregnancy Through Targeted and Discovery Exposomics™ Exposomics provides a comprehensive approach to characterize exogenous chemical exposures during pregnancy by profiling compounds in maternal and placental samples. In this adverse pregnancy study, Discovery Exposomics and Targeted Exposomics identified exposure profiles across maternal serum and placental tissue, revealing both shared and tissue-specific chemical […]
How Genomics and Exposomics Will Transform Precision Medicine Genomics has transformed precision medicine by revealing an individual’s genetic blueprint—but genetics alone cannot explain why people with similar genomes often experience very different health outcomes. In this episode of ChatGJP, Panome Bio CEO Ed Weinstein explains how exposomics adds the missing layer by measuring the environmental […]
How Exposomics Can Improve Clinical Trials and Precision Medicine Why do promising drugs fail in Phase III clinical trials? Why do patients respond differently to the same therapy across countries? And if genetics only explains part of disease risk, what information is missing? In this episode of ChatGJP, Tom Cohen, President of Panome Bio, discusses […]